Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 5
1976 3
1977 1
1980 2
1982 1
1985 2
1989 1
1990 3
1991 4
1992 2
1993 2
1994 4
1995 5
1996 14
1997 7
1998 21
1999 11
2000 21
2001 9
2002 11
2003 8
2004 7
2005 12
2006 14
2007 11
2008 12
2009 11
2010 18
2011 19
2012 16
2013 22
2014 23
2015 23
2016 30
2017 31
2018 24
2019 35
2020 29
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

448 results
Results by year
Filters applied: . Clear all
Page 1
Cerebrolysin for acute ischaemic stroke.
Ziganshina LE, Abakumova T, Vernay L. Ziganshina LE, et al. Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD007026. doi: 10.1002/14651858.CD007026.pub5. Cochrane Database Syst Rev. 2017. PMID: 28430363 Free PMC article. Updated. Review.
BACKGROUND: Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pigs' brain tissue, which has potential neuroprotective and neurotrophic properties. ...AUTHORS' CONCLUSIONS: The findings of this Cochrane Review do not demonstrate clinica …
BACKGROUND: Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pigs' brain tissue, which has pot …
Cerebrolysin for vascular dementia.
Cui S, Chen N, Yang M, Guo J, Zhou M, Zhu C, He L. Cui S, et al. Cochrane Database Syst Rev. 2019 Nov 11;2019(11):CD008900. doi: 10.1002/14651858.CD008900.pub3. Cochrane Database Syst Rev. 2019. PMID: 31710397 Free PMC article.
Secondary: to assess the adverse effects of Cerebrolysin and to assess the effect of Cerebrolysin on quality of life and caregiver burden. ...There have been no new studies of Cerebrolysin in vascular dementia since the last Cochrane Review. Cerebrolysin
Secondary: to assess the adverse effects of Cerebrolysin and to assess the effect of Cerebrolysin on quality of life and careg …
[Depression and cognitive decline in elderly: causes and consequences].
Levin OS, Vasenina EE. Levin OS, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(7):87-94. doi: 10.17116/jnevro201911907187. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31464295 Russian.
The diagnostic differentiation between depression and dementia at different stages of dementia as well as in younger and older ages, a role of depression as a risk factor for dementia, a role of other factors, in particular age, as well as treatment approaches on the example of a …
The diagnostic differentiation between depression and dementia at different stages of dementia as well as in younger and older ages, a role …
Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1alpha Pathway.
Guan X, Wang Y, Kai G, Zhao S, Huang T, Li Y, Xu Y, Zhang L, Pang T. Guan X, et al. Front Pharmacol. 2019 Oct 22;10:1245. doi: 10.3389/fphar.2019.01245. eCollection 2019. Front Pharmacol. 2019. PMID: 31695614 Free PMC article.
Neuroinflammation is one of the important factors aggravating brain injury after ischemic stroke. We aimed to investigate the effects of cerebrolysin (CBL) on neuroinflammation in vivo and in vitro and the underlying mechanisms. ...
Neuroinflammation is one of the important factors aggravating brain injury after ischemic stroke. We aimed to investigate the effects of …
[Cerebrolysin peptides as mood stabilizers].
Torshin IY, Gromova OA, Zgoda VG, Tikhonova OV, Malyavskaya SI. Torshin IY, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(12):69-75. doi: 10.17116/jnevro201911912169. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31994517 Russian.
AIM: To establish the molecular mechanisms of the mood stabilizing (normothymic) action of the neuroprotector Cerebrolysin. MATERIAL AND METHODS: Mass-spectrometric analysis of the peptide composition of cerebrolysin followed by a complex bioinformatics analysis was …
AIM: To establish the molecular mechanisms of the mood stabilizing (normothymic) action of the neuroprotector Cerebrolysin. MATERIAL …
Cerebrolysin: a multi-target drug for recovery after stroke.
Brainin M. Brainin M. Expert Rev Neurother. 2018 Aug;18(8):681-687. doi: 10.1080/14737175.2018.1500459. Epub 2018 Jul 18. Expert Rev Neurother. 2018. PMID: 30004268 Review.
Cerebrolysin is a neuropeptide preparation with neurotrophic effects and promotes recovery after brain injury. ...Based on the findings from several studies, it became evident that the effect size of Cerebrolysin was increasing with stroke severity. Other controlled
Cerebrolysin is a neuropeptide preparation with neurotrophic effects and promotes recovery after brain injury. ...Based on the findin
Cerebrolysin for acute ischaemic stroke.
Ziganshina LE, Abakumova T, Hoyle CH. Ziganshina LE, et al. Cochrane Database Syst Rev. 2020 Jul 14;7(7):CD007026. doi: 10.1002/14651858.CD007026.pub6. Cochrane Database Syst Rev. 2020. PMID: 32662068
Only one trial clearly reported on the cause of death: cerebral infarct (four in the Cerebrolysin and two in the placebo group), heart failure (two in the Cerebrolysin and one in the placebo group), pulmonary embolism (two in the placebo group), and pneumonia (one i …
Only one trial clearly reported on the cause of death: cerebral infarct (four in the Cerebrolysin and two in the placebo group), hear …
Cerebrolysin for acute ischaemic stroke.
Ziganshina LE, Abakumova T, Vernay L. Ziganshina LE, et al. Cochrane Database Syst Rev. 2016 Dec 5;12(12):CD007026. doi: 10.1002/14651858.CD007026.pub4. Cochrane Database Syst Rev. 2016. PMID: 27918088 Free PMC article. Updated. Review.
BACKGROUND: Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pigs' brain tissue, which has potential neuroprotective and neurotrophic properties. ...AUTHORS' CONCLUSIONS: The findings of this Cochrane Review do not demonstrate clinica …
BACKGROUND: Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pigs' brain tissue, which has pot …
Efficacy of Neuroprotective Drugs in Acute Ischemic Stroke: Is It Helpful?
Mehta A, Mahale R, Buddaraju K, Javali M, Acharya P, Srinivasa R. Mehta A, et al. J Neurosci Rural Pract. 2019 Oct;10(4):576-581. doi: 10.1055/s-0039-1700790. Epub 2019 Dec 11. J Neurosci Rural Pract. 2019. PMID: 31831974 Free PMC article.
Objective The purpose is to evaluate the efficacy of citicoline, edaravone, minocycline, and cerebrolysin compared with placebo in patients with middle cerebral artery (MCA) territory AIS. ...Results The mean NIHSS score was significantly lesser at day 11 and after 90 days …
Objective The purpose is to evaluate the efficacy of citicoline, edaravone, minocycline, and cerebrolysin compared with placebo in pa …
Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure.
Kang DH, Choi BY, Lee SH, Kho AR, Jeong JH, Hong DK, Kang BS, Park MK, Song HK, Choi HC, Lim MS, Suh SW. Kang DH, et al. Front Neurosci. 2020 Oct 16;14:568813. doi: 10.3389/fnins.2020.568813. eCollection 2020. Front Neurosci. 2020. PMID: 33177978 Free PMC article.
However, the effects of cerebrolysin on seizures are not known. Therefore, this study aimed to investigate the effects of neuropeptide cerebrolysin on neuronal death in the hippocampus after a seizure. To confirm the effects of cerebrolysin, we used a pilocar …
However, the effects of cerebrolysin on seizures are not known. Therefore, this study aimed to investigate the effects of neuropeptid …
448 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page